Suven Life Sciences Limited (NSE:SUVEN)
138.45
-0.84 (-0.60%)
Feb 2, 2026, 3:29 PM IST
Suven Life Sciences Statistics
Total Valuation
NSE:SUVEN has a market cap or net worth of INR 32.31 billion. The enterprise value is 29.74 billion.
| Market Cap | 32.31B |
| Enterprise Value | 29.74B |
Important Dates
The last earnings date was Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 231.95M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 28.08% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 457.56 |
| PB Ratio | 11.49 |
| P/TBV Ratio | 11.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.83 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1,188.91% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.21% |
| Revenue Per Employee | 511,710 |
| Profits Per Employee | -19.91M |
| Employee Count | 138 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.16% in the last 52 weeks. The beta is 0.36, so NSE:SUVEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +4.16% |
| 50-Day Moving Average | 161.61 |
| 200-Day Moving Average | 202.71 |
| Relative Strength Index (RSI) | 39.56 |
| Average Volume (20 Days) | 363,801 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUVEN had revenue of INR 70.62 million and -2.75 billion in losses. Loss per share was -12.35.
| Revenue | 70.62M |
| Gross Profit | 63.10M |
| Operating Income | -2.83B |
| Pretax Income | -2.75B |
| Net Income | -2.75B |
| EBITDA | -2.78B |
| EBIT | -2.83B |
| Loss Per Share | -12.35 |
Balance Sheet
The company has 2.57 billion in cash and n/a in debt, with a net cash position of 2.57 billion.
| Cash & Cash Equivalents | 2.57B |
| Total Debt | n/a |
| Net Cash | 2.57B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.81B |
| Book Value Per Share | 12.66 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 89.36% |
| Operating Margin | -4,002.84% |
| Pretax Margin | -3,889.96% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NSE:SUVEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | -8.50% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |